In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9.
In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9.
复制标题
细胞色素 P450 2C9 基因分型的食蟹猴中依非韦伦药代动力学的体内个体差异。
DOI:
10.1002/bdd.2021
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
H.
中科院分区:
文献类型:
--
作者:
Iwasaki;K.;Kitsugi;Y.;Ikeda;K.;Yoshikawa;T.;Hosaka;S.;Uehara;S.;Uno;Y.;Utoh;M.;and Yamazaki;H.
Cynomolgus monkeys are used frequently in preclinical studies for new drug development due to their evolutionary closeness to humans. An antiretroviral drug, efavirenz, is a typical probe substrate for human cytochrome P450 (P450) 2B6, but is mainly metabolized by cynomolgus monkey P450 2C9. In this study, plasma concentrations of efavirenz were assessed in six cynomolgus monkeys genotyped forP450 2C9c.334 A > C (I112L) (three wild‐type, one heterozygote and two homozygotes) by high performance liquid chromatography with tandem mass spectrometry. After intravenous administration at a dose of 1.0 mg/kg, biphasic plasma elimination curves of efavirenz were seen in these cynomolgus monkeys. The mean plasma concentration of the primary metabolite 8‐hydroxyefavirenz (1 h after treatment, with hydrolysis by β‐glucuronidase) in the wild‐type group was significantly higher (4.0‐fold) than the combined heterozygous and homozygous group mean. The area under the plasma concentration–time curve value of efavirenz in the homozygous group after oral administration at a dose of 2.0 mg/kg was significantly higher (2.0‐fold) than the combined wild‐type and heterozygous group. These results collectively indicated thatP450 2C9c.334 A > C (I112L) variation was associated with efavirenz metabolic clearancein vivo.CynomolgusP450 2C9polymorphism might account for interindividual variations of efavirenz metabolism in cynomolgus monkeys. Copyright © 2016 John Wiley & Sons, Ltd.